MeSH D005767 - gastrointestinal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005767:Â
Gastrointestinal diseases
D000079562:Rumination syndrome
0 Companies
0 Drugs
Success rate
D004935:Esophageal diseases
D005759:Gastroenteritis
D005770:Gastrointestinal neoplasms
D006471:Gastrointestinal hemorrhage
D007410:Intestinal diseases
0 Companies
0 Drugs
Success rate
D013272:Stomach diseases
D014385:Gastrointestinal tuberculosis
0 Companies
0 Drugs
Success rate
D014782:Visceral prolapse
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  | |
| Sandoz | Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1983-08-25 |  |  | |
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin |  | 1984-10-29 |  |  |
| Bausch Health Companies | Dexamethasone, Neomycin, Polymyxin b | Dexasporin |  | 1995-09-13 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1994-07-25 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1995-12-29 |  |  | |
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone |  | 1995-10-30 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Oticair |  | 1996-08-28 |  |  | |
| Merck Sharp & Dohme | Hydrocortisone, Neomycin, Polymyxin b | Otobione |  | 1982-01-01 |  |  |
| Hydrocortisone, Polymyxin b | Otobiotic |  | 1982-01-01 |  |  | |
| Allergan | Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  |
| Forest Laboratories | Hydrocortisone, Polymyxin b | Pyocidin |  | 1982-01-01 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
78%7/9
Phase 2
27%7/26
Phase 3
17%2/12
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use